Neuraminidase inhibitors for influenza A and B: antivirals need to be protected from adverse conditions to retain effectiveness
- PMID: 12855538
- PMCID: PMC1126465
- DOI: 10.1136/bmj.327.7406.105-c
Neuraminidase inhibitors for influenza A and B: antivirals need to be protected from adverse conditions to retain effectiveness
Comment on
-
Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.BMJ. 2003 Jun 7;326(7401):1235. doi: 10.1136/bmj.326.7401.1235. BMJ. 2003. PMID: 12791735 Free PMC article.
References
-
- Physicians' desk reference 56th ed. Montvale: Medical Economics, 2002.
-
- Bidshai DM, Bhatt S, Miller LT, Hayden GF. Vaccine storage practices in pediatric offices. Pediatrics 1992;89: 193-6. - PubMed
-
- Verheyden B, Andrus K, Rombart B. Capsid and viral RNA stabilization of the poliovirus. Vaccine 2001;19: 1899-905. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical